Format

Send to

Choose Destination
Expert Opin Ther Targets. 2007 May;11(5):717-22.

Towards the discovery of novel T-type calcium channel blockers.

Author information

1
Institut de Génomique Fonctionnelle, Département de Physiologie, CNRS UMR 5203, INSERM U661, IFR3, Universités de Montpellier I and II, Montpellier cedex 05, France. philippe.lory@igf.cnrs.fr

Abstract

Despite their presence in many tissues and their potential implication in various disease states, low-voltage activated T-type calcium channels (T-channels) have only recently become targets of interest. Unfortunately, the lack of selective T-channel blockers has hampered further characterisation of these channels. The recent availability of cloned T-channels, the Ca(V)3 proteins, facilitates identification of novel T-channel blockers. Also, studies performed in knockout animals have fostered novel interest. Selective inhibition of T-channels may have clinical importance in cardiovascular diseases, some forms of epilepsy, sleep disorders, pain and possibly cancer. This review focuses on novel research approaches to discover potent and selective T-channel modulators. These molecules may be potential drugs for treating human diseases, as well as important tools to decipher the physiological role of these channels.

PMID:
17465728
DOI:
10.1517/14728222.11.5.717
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center